Twelves, C. et al. (2002) Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme. Annals of Oncology, 13(5), pp. 777-780.
Full text not currently available from Enlighten.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Rampling, Professor Roy |
| Authors: | Twelves, C., Campone, M., Coudert, B., Van den Bent, M., de Jonge, M., Dittrich, C., Rampling, R., Sorio, R., Lacombe, D., de Balincourt, C., and Fumoleau, P. |
| College/School: | College of Medical Veterinary and Life Sciences |
| Journal Name: | Annals of Oncology |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details